Atlas Trials

Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?

Clinical trial NCT04336696 · UNKNOWN

Trial details

NCT number
NCT04336696
Sponsor
Bassem Mohamed Sieda
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Papillary Thyroid Carcinoma
Start date
2016-11-02
Primary completion
2020-04-03
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.